Evidence map›Paper›PMID 36425630›Full record

ArticleBiomedical optics express2022

Maria Vinas-Pena, Xu Feng, Guo-Yang Li, Seok-Hyun Yun

Open access · goldAbstract read
In one paragraph

Article in Biomedical optics express, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Analysis of In Vivo Sclera Impact on the Biomechanics of Myopic Eyes.Translational vision science & technology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maria Vinas-PenaWellman Center for Photomedicine and Harvard Medical School, Massachusetts General Hospital, 50 Blossom St., Boston, MA, USA.ORCID https://orcid.org/0000-0003-1296-9508
Xu FengWellman Center for Photomedicine and Harvard Medical School, Massachusetts General Hospital, 50 Blossom St., Boston, MA, USA.ORCID https://orcid.org/0000-0002-9048-7144
Guo-Yang LiWellman Center for Photomedicine and Harvard Medical School, Massachusetts General Hospital, 50 Blossom St., Boston, MA, USA.
Seok-Hyun YunWellman Center for Photomedicine and Harvard Medical School, Massachusetts General Hospital, 50 Blossom St., Boston, MA, USA.
Harvard University · US

Funding

Development of stimulated Brillouin microscopy for high-resolution stiffness measurementR01EB027653 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI YUN, SEOK-HYUN ANDY · 2019 to 2023
$2.0M
Brillouin optical eye scanner prototypes for commercializationR42EY028820 · NEI · INTELON OPTICS, INC. · PI CHERNYAK, DIMITRI, YUN, SEOK-HYUN ANDY · 2021 to 2022
$1.2M
NEI NIH HHS R42 EY028820NIBIB NIH HHS R01 EB027653
6 · The paper itself

Abstract

Scleral crosslinking may provide a way to prevent or treat myopia by stiffening scleral tissues. The ability to measure the stiffness of scleral tissues

Identifiers

PMID36425630
PMCPMC9664890
OpenAlexW4292728609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.